Correlation between expression of leukocyte alkaline phosphatase and prognosis in myelodysplastic syndromes.

被引：0
|
作者：
Okamoto, T
Okada, M
Yamada, S
Fujimori, Y
Takemoto, Y
Masuhara, K
Okamura, H
Kakishita, E
机构：
[1] Hyogo Coll Med, Dept Internal Med 2, Nishinomiya, Hyogo, Japan
[2] Hyogo Coll Med, Host Def Lab, Nishinomiya, Hyogo, Japan
[3] Osaka Univ, Dept Orthoped Surg, Suita, Osaka 565, Japan
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4089
引用
收藏
页码：253B / 253B
页数：1
相关论文
共 50 条
  • [21] Loss of p21ras, p53, and mdm2 protein expression is indicative of worse prognosis in myelodysplastic syndromes.
    Schulz, E
    Lorand-Metze, I
    Koch, R
    Costa, SC
    Costa, FF
    Saad, STO
    BLOOD, 2004, 104 (11) : 936A - 936A
  • [22] Analysis of gene mutation characteristics and its correlation with prognosis in patients with myelodysplastic syndromes
    Yang, Xinyu
    Zhao, Hongyu
    Wu, Hanyang
    Guo, Xiaodong
    Jia, Hexiao
    Liu, Wancheng
    Wei, Yihong
    Can, Can
    Ma, Daoxin
    CLINICA CHIMICA ACTA, 2024, 554
  • [23] CORRELATION BETWEEN SERUM ALKALINE PHOSPHATASE AND PLACENTAL INSUFFICIENCY
    PYSTYNEN, P
    PENTTILA, I
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1971, 50 : 59 - &
  • [24] BCL-2 EXPRESSION IN MYELODYSPLASTIC SYNDROMES AND ITS CORRELATION WITH HEMATOLOGICAL FEATURES, P53 MUTATIONS AND PROGNOSIS
    LEPELLEY, P
    SOENEN, V
    PREUDHOMME, C
    MERLAT, A
    COSSON, A
    FENAUX, P
    LEUKEMIA, 1995, 9 (04) : 726 - 730
  • [25] Reduced CD38 Expression on CD34+Cells as a Diagnostic Test in Myelodysplastic Syndromes.
    Vyas, Paresh
    Goardon, Nicolas
    Stemberg, Alexander
    Chu, Wai-Kit
    Craddock, Charles F.
    Benson, Richard
    Freeman, Sylvie
    BLOOD, 2008, 112 (11) : 922 - 923
  • [26] MYELODYSPLASTIC SYNDROMES: USEFULNESS OF GENE EXPRESSION PROFILING FOR PROGNOSIS AND CELL MORPHOLOGY CLASSIFICATION
    Cabezon, M.
    Zamora, L.
    Berenguer, T.
    Marce, S.
    Lloveras, N.
    Xicoy, B.
    Dominguez, D.
    Ribera, J.
    Portal, I.
    Guardia, R.
    Vela, D.
    Ayats, J.
    Buch, J.
    Grifols, J. R.
    Xandri, M.
    Moreno, V.
    Ribera, J. M.
    Milla, F.
    Feliu, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 16 - 16
  • [27] Decreased FOXO1 Expression Is Correlated with Poor Prognosis in Myelodysplastic Syndromes
    Zhang, Zheng
    Huang, Nanfang
    Xv, Feng
    Zhao, Sida
    Guo, Juan
    Zhao, Youshan
    Chang, Chunkang
    CURRENT ONCOLOGY, 2022, 29 (10) : 6933 - 6946
  • [28] IMMUNE FUNCTION PARAMETERS AT DIAGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - CORRELATION WITH THE FAB CLASSIFICATION AND PROGNOSIS
    SYMEONIDIS, A
    KOURAKLI, A
    KATEVAS, P
    PERRAKI, M
    TINIAKOU, M
    MATSOUKA, P
    GEORGOULIAS, V
    ZOUMBOS, N
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 47 (04) : 277 - 281
  • [29] Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients
    Okamoto, T
    Okada, M
    Mori, A
    Saheki, K
    Takatsuka, H
    Wada, H
    Tamura, A
    Fujimori, Y
    Takemoto, Y
    Kanamaru, A
    Kakishita, E
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 66 (03) : 345 - 351
  • [30] SYNERGISM BETWEEN ATRA AND CAMP IN THE EXPRESSION OF LEUKOCYTE ALKALINE-PHOSPHATASE IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS
    GARATTINI, E
    GIANNI, M
    RAMBALDI, A
    TERAO, M
    FASEB JOURNAL, 1995, 9 (04): : A676 - A676
12345